Aravax is a clinical-stage biotechnology company developing the first safe and rapidly effective treatment for peanut allergy.
Clinical Trials

Clinical trial AVX-001 and follow-up study AVX-001-ext are the first studies of PVX108 to be conducted in humans.

Recent News